fluticasone propionate and salmeterol

Product NDC: 0093-7517
11-digit product format: 000937517
Labeler code: 0093
Product ID: 0093-7517_2c0a7e7d-224f-4fd8-abf1-05f65fb12f5b
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: fluticasone propionate and salmeterol
Dosage form: POWDER
Route: RESPIRATORY (INHALATION)
Labeler: Teva Pharmaceuticals USA, Inc.
Application: ANDA213948
Marketing category: ANDA
Marketing start: 2022-03-23
Substance: FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE
Active strength: 100; 50 ug/1; ug/1
Pharmacologic classes: Adrenergic beta2-Agonists [MoA], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], beta2-Adrenergic Agonist [EPC]
NDC exclude flag: No
Listing certified through: 2026-12-31
Current FDA listing: Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 3 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	Approval date
A213948-001	FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE	FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE	0.1MG/INH;EQ 0.05MG BASE/INH	POWDER / INHALATION	AB	2021-12-13
A213948-002	FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE	FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE	0.25MG/INH;EQ 0.05MG BASE/INH	POWDER / INHALATION	AB	2021-12-13
A213948-003	FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE	FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE	0.5MG/INH;EQ 0.05MG BASE/INH	POWDER / INHALATION	AB	2021-12-13

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 3 matching rows.

Application-product, TE code table
Application-product	TE code
A213948-001	AB
A213948-002	AB
A213948-003	AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 3 · 96 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A213948-001	FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE	0.1MG/INH;EQ 0.05MG BASE/INH	POWDER / INHALATION	AB	2021-12-13	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A213948-002	FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE	0.25MG/INH;EQ 0.05MG BASE/INH	POWDER / INHALATION	AB	2021-12-13	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A213948-003	FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE	0.5MG/INH;EQ 0.05MG BASE/INH	POWDER / INHALATION	AB	2021-12-13	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A213948-001	FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE	0.1MG/INH;EQ 0.05MG BASE/INH	POWDER / INHALATION	AB	2021-12-13	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A213948-002	FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE	0.25MG/INH;EQ 0.05MG BASE/INH	POWDER / INHALATION	AB	2021-12-13	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A213948-003	FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE	0.5MG/INH;EQ 0.05MG BASE/INH	POWDER / INHALATION	AB	2021-12-13	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A213948-001	FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE	0.1MG/INH;EQ 0.05MG BASE/INH	POWDER / INHALATION	AB	2021-12-13	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A213948-002	FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE	0.25MG/INH;EQ 0.05MG BASE/INH	POWDER / INHALATION	AB	2021-12-13	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A213948-003	FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE	0.5MG/INH;EQ 0.05MG BASE/INH	POWDER / INHALATION	AB	2021-12-13	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A213948-001	FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE	0.1MG/INH;EQ 0.05MG BASE/INH	POWDER / INHALATION	AB	2021-12-13	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A213948-002	FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE	0.25MG/INH;EQ 0.05MG BASE/INH	POWDER / INHALATION	AB	2021-12-13	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A213948-003	FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE	0.5MG/INH;EQ 0.05MG BASE/INH	POWDER / INHALATION	AB	2021-12-13	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A213948-001	FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE	0.1MG/INH;EQ 0.05MG BASE/INH	POWDER / INHALATION	AB	2021-12-13	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A213948-002	FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE	0.25MG/INH;EQ 0.05MG BASE/INH	POWDER / INHALATION	AB	2021-12-13	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A213948-003	FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE	0.5MG/INH;EQ 0.05MG BASE/INH	POWDER / INHALATION	AB	2021-12-13	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A213948-001	FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE	0.1MG/INH;EQ 0.05MG BASE/INH	POWDER / INHALATION	AB	2021-12-13	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A213948-002	FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE	0.25MG/INH;EQ 0.05MG BASE/INH	POWDER / INHALATION	AB	2021-12-13	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A213948-003	FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE	0.5MG/INH;EQ 0.05MG BASE/INH	POWDER / INHALATION	AB	2021-12-13	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A213948-001	FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE	0.1MG/INH;EQ 0.05MG BASE/INH	POWDER / INHALATION	AB	2021-12-13	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A213948-002	FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE	0.25MG/INH;EQ 0.05MG BASE/INH	POWDER / INHALATION	AB	2021-12-13	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A213948-003	FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE	0.5MG/INH;EQ 0.05MG BASE/INH	POWDER / INHALATION	AB	2021-12-13	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A213948-001	FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE	0.1MG/INH;EQ 0.05MG BASE/INH	POWDER / INHALATION	AB	2021-12-13	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A213948-002	FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE	0.25MG/INH;EQ 0.05MG BASE/INH	POWDER / INHALATION	AB	2021-12-13	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A213948-003	FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE	0.5MG/INH;EQ 0.05MG BASE/INH	POWDER / INHALATION	AB	2021-12-13	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A213948-001	FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE	0.1MG/INH;EQ 0.05MG BASE/INH	POWDER / INHALATION	AB	2021-12-13	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A213948-002	FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE	0.25MG/INH;EQ 0.05MG BASE/INH	POWDER / INHALATION	AB	2021-12-13	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A213948-003	FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE	0.5MG/INH;EQ 0.05MG BASE/INH	POWDER / INHALATION	AB	2021-12-13	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A213948-001	FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE	0.1MG/INH;EQ 0.05MG BASE/INH	POWDER / INHALATION	AB	2021-12-13	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A213948-002	FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE	0.25MG/INH;EQ 0.05MG BASE/INH	POWDER / INHALATION	AB	2021-12-13	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A213948-003	FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE	0.5MG/INH;EQ 0.05MG BASE/INH	POWDER / INHALATION	AB	2021-12-13	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A213948-001	FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE	0.1MG/INH;EQ 0.05MG BASE/INH	POWDER / INHALATION	AB	2021-12-13	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A213948-002	FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE	0.25MG/INH;EQ 0.05MG BASE/INH	POWDER / INHALATION	AB	2021-12-13	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A213948-003	FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE	0.5MG/INH;EQ 0.05MG BASE/INH	POWDER / INHALATION	AB	2021-12-13	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A213948-001	FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE	0.1MG/INH;EQ 0.05MG BASE/INH	POWDER / INHALATION	AB	2021-12-13	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A213948-002	FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE	0.25MG/INH;EQ 0.05MG BASE/INH	POWDER / INHALATION	AB	2021-12-13	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A213948-003	FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE	0.5MG/INH;EQ 0.05MG BASE/INH	POWDER / INHALATION	AB	2021-12-13	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A213948-001	FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE	0.1MG/INH;EQ 0.05MG BASE/INH	POWDER / INHALATION	AB	2021-12-13	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A213948-002	FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE	0.25MG/INH;EQ 0.05MG BASE/INH	POWDER / INHALATION	AB	2021-12-13	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A213948-003	FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE	0.5MG/INH;EQ 0.05MG BASE/INH	POWDER / INHALATION	AB	2021-12-13	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A213948-001	FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE	0.1MG/INH;EQ 0.05MG BASE/INH	POWDER / INHALATION	AB	2021-12-13	`8072bd15b7f6…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 3 · 96 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A213948-001	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A213948-002	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A213948-003	AB	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A213948-001	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A213948-002	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A213948-003	AB	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A213948-001	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A213948-002	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A213948-003	AB	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A213948-001	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A213948-002	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A213948-003	AB	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A213948-001	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A213948-002	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A213948-003	AB	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A213948-001	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A213948-002	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A213948-003	AB	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A213948-001	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A213948-002	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A213948-003	AB	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A213948-001	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A213948-002	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A213948-003	AB	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A213948-001	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A213948-002	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A213948-003	AB	1	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A213948-001	AB	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A213948-002	AB	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A213948-003	AB	1	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A213948-001	AB	1	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A213948-002	AB	1	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A213948-003	AB	1	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A213948-001	AB	1	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A213948-002	AB	1	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A213948-003	AB	1	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A213948-001	AB	1	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A213948-002	AB	1	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A213948-003	AB	1	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A213948-001	AB	1	`8072bd15b7f6…`

Additional Listing Data#

Finished product: Yes
Brand name base: fluticasone propionate and salmeterol
Listing expiration: 2026-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
FLUTICASONE PROPIONATE	100 ug/1
SALMETEROL XINAFOATE	50 ug/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 2 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
6EW8Q962A5	Internal UNII lookup
O2GMZ0LF5W	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 3 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
896184	Internal RxNorm lookup
896209	Internal RxNorm lookup
896228	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
ce347bf4-4cc1-46dc-b5f1-6f8ff48da84b	Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
f4fb2f5a-dadb-40e3-a4b1-a2a58f5d9a33	Product name	3	20260126
343e8617-eb68-1e10-cfa9-8c30af285764	Product name	3	20240513
a31ad3df-8021-2ea1-94eb-0fe2f49b7729	Product name	4	20220719
813fe018-3e3c-40e4-8f71-7ab50f3dfe81	Product name	2	20180723
3bcd721e-0555-4bc3-96c6-690471ff9d94	Product name	1	20171113
9f9452df-fa34-43d4-97fe-c6605344c5a8	Product name	1	20171113
0e5a25a6-9f05-44b5-8449-aa63e59f7202	Product name	1	20170426
f3c5232f-03de-44f5-996a-90cd9c08bc60	Product name	1	20170426
1cb17fbb-0da4-2841-37bc-e7079783e1a2	Product name	1	20140508
667f427a-8698-a508-767a-53ed61b4c2e9	Product name	1	20140508
6a97ffc8-1d4d-a971-4978-85ba3a22eac9	Product name	1	20140508
6df84e13-2223-fa46-1e26-17e2f58a1e1c	Product name	1	20140508
811691fa-281f-6d95-fb49-e2337fb2e146	Product name	1	20140508
90fec588-984c-4375-cfd4-7e40114bdf80	Product name	1	20140508
9c1d3c48-b162-204b-f55b-e0f25c31c52e	Product name	1	20140508
9fdb6139-394b-1510-4baf-bde68c419789	Product name	1	20140508
aef26912-037b-9a4e-db49-225ef6dfd8f1	Product name	1	20140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
0093-7517-31	fluticasone propionate and salmeterol	1 in 1 POUCH	POWDER	1		6
0093-7517-31	fluticasone propionate and salmeterol	1 in 1 CARTON	POWDER	1		6

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
0093-7517-31	EA - Each	0093-7517	b2dec9b0-fdfa-40a5-a551-667eab0ce96c	1	2022-04-06

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
0093-7517	FLUTICASONE PROPIONATE AND SALMETEROL POWDER [TEVA PHARMACEUTICALS USA, INC.]	6	Current NDC, Legacy NDC, 2 package rows	20220929_ce347bf4-4cc1-46dc-b5f1-6f8ff48da84b.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
fluticasone propionate and salmeterol	FLUTICASONE PROPIONATE AND SALMETEROL	Teva Pharmaceuticals USA, Inc.	ce347bf4-4cc1-46dc-b5f1-6f8ff48da84b	2022-09-28	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 213948 application number: ANDA213948 ndc (product): 0093-7517

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
O2GMZ0LF5W	FLUTICASONE PROPIONATE	80474-14-2	FLUTICASONE PROPIONATE
6EW8Q962A5	SALMETEROL XINAFOATE	94749-08-3	SALMETEROL XINAFOATE

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
896184	fluticasone propionate/salmeterol 100/50 MCG/INHAL Dry Powder Inhaler, 60 Blisters	PSN	ce347bf4-4cc1-46dc-b5f1-6f8ff48da84b	6
896209	fluticasone propionate/salmeterol 250/50 MCG/INHAL Dry Powder Inhaler, 60 Blisters	PSN	ce347bf4-4cc1-46dc-b5f1-6f8ff48da84b	6
896228	fluticasone propionate/salmeterol 500/50 MCG/INHAL Dry Powder Inhaler, 60 Blisters	PSN	ce347bf4-4cc1-46dc-b5f1-6f8ff48da84b	6
896184	60 ACTUAT fluticasone propionate 0.1 MG/ACTUAT / salmeterol 0.05 MG/ACTUAT Dry Powder Inhaler	SCD	ce347bf4-4cc1-46dc-b5f1-6f8ff48da84b	6
896209	60 ACTUAT fluticasone propionate 0.25 MG/ACTUAT / salmeterol 0.05 MG/ACTUAT Dry Powder Inhaler	SCD	ce347bf4-4cc1-46dc-b5f1-6f8ff48da84b	6
896228	60 ACTUAT fluticasone propionate 0.5 MG/ACTUAT / salmeterol 0.05 MG/ACTUAT Dry Powder Inhaler	SCD	ce347bf4-4cc1-46dc-b5f1-6f8ff48da84b	6
896184	fluticasone propionate 0.1 MG/ACTUAT / salmeterol 0.05 MG/ACTUAT Dry Powder Inhaler, 60 ACTUAT	SY	ce347bf4-4cc1-46dc-b5f1-6f8ff48da84b	6
896209	fluticasone propionate 0.25 MG / salmeterol 0.05 MG per ACTUAT Dry Powder Inhaler, 60 ACTUAT	SY	ce347bf4-4cc1-46dc-b5f1-6f8ff48da84b	6
896228	fluticasone propionate 0.5 MG / salmeterol 0.05 MG per ACTUAT Dry Powder Inhaler, 60 ACTUAT	SY	ce347bf4-4cc1-46dc-b5f1-6f8ff48da84b	6
896184	fluticasone propionate 100 MCG / salmeterol 50 MCG (salmeterol xinafoate 72.5 MCG) per ACTUAT Dry Powder Inhaler, 60 ACTUAT	SY	ce347bf4-4cc1-46dc-b5f1-6f8ff48da84b	6
896209	fluticasone propionate 250 MCG / salmeterol 50 MCG (salmeterol xinafoate 72.5 MCG) per ACTUAT Dry Powder Inhaler, 60 ACTUAT	SY	ce347bf4-4cc1-46dc-b5f1-6f8ff48da84b	6
896228	fluticasone propionate 500 MCG / salmeterol 50 MCG (salmeterol xinafoate 72.5 MCG) per ACTUAT Dry Powder Inhaler, 60 ACTUAT	SY	ce347bf4-4cc1-46dc-b5f1-6f8ff48da84b	6

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
0093-7517-31	00093751731	1 POUCH in 1 CARTON (0093-7517-31) / 1 INHALER in 1 POUCH / 60 POWDER in 1 INHALER	1 pouch	2022-03-23	0000-00-00	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
fluticasone propionate and salmeterol - Teva Pharmaceuticals USA, Inc.	Teva Pharmaceuticals USA, Inc.	2022-09-28	HUMAN PRESCRIPTION DRUG LABEL	6